2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Island Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Examine the Effects of Oral Fenretinide ISLA101, Dengue 1 Live Virus Human Challenge (DENV-1-LVHC), Placebo - Dengue | Phase 2 | Completed | Island Pharmaceuticals | 15 | 2024-09-05 | 2025-10-24 |
| A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers Fenretinide, Placebo - Safety and Tolerability | Phase 1 | Completed | Island Pharmaceuticals | 25 | 2023-11-22 | 2025-01-27 |
Dengue (1)
Fenretinide (2)
Australia (1) · United States (1)
Bert Slade, MD (1) · Christopher Argent, MD (1)